MYC and fibrosarcoma: This makes c-Myc a relevant “driver” for tumorigenicity in the fibrosarcoma HT-1080 cells, as reported by the proliferation effect induced by gene knock-down [20], and explains the reduced tumorigenic potential evoked by SEN461 treatment.